- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in sun pharma
Sun Pharma's Halol Facility In USFDA's 'Import Alert List', US Entry Restricted For Products
The Import Alert implies interalia, that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until the facility becomes compliant with cGMP standards
Read More
Q2 Results: Sun Pharma Sales Up By 10% YoY, Records Net profit Of 2,262 Cr
The company’s sales in India saw a jump of 8.5 per cent to Rs 3,460 crore, a rise of 8.5 per cent against the second quarter of last year. At the same time, the sales in the US were up by 27.5 per cent quarter on quarter and stood at USD 200 million
Read More
Pharma Such As Glenmark, Sun Pharma, Dr Reddy's Recall Drugs In US
As per the USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. "As per the USFDA, Sun Pharma is recalling 9,552 bottles of epilepsy treatment drug Divalproex Sodium delayed-release tablets due to "Failed Dissolution Specifications"
Read More
Sun Pharma, Glenmark Recalling Products From US Due To Manufacturing Woes
As per the latest enforcement report by the US Food and Drug Administration (USFDA), a US-based unit of Sun Pharma is recalling 50,680 vials of Testosterone Cypionate Injection, used to treat low testosterone in adult males, in the American market
Read More
Sun Pharma To Expand Field Force In India By 10% In FY23
Supported by more than 40 manufacturing facilities, Sun Pharma caters to more than 100 countries across the globe
Read More
Sun Pharma Eyes High Single Digit Top Line Growth In FY23: Dilip Shanghvi
On its Halol-based manufacturing plant, he stated that the company will be filing its response to the FDA on the corrective actions to be undertaken to address the observations within the stipulated time
Read More
Sun Pharma, Ranbaxy Inc Sign Pact With 2 Plaintiff Groups To Settle Claims
Sun Pharma said has disputed the claims of the plaintiffs and defended these matters vigorously
Read More
Sun Pharma To Set Up An End-To-End Manufacturing Facility In Andhra Pradesh
Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over US$ 4.5 billion. Supported by more than 40 manufacturing facilities, they provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Read More
Sun Pharma, Lupin Recall Products In US Market, Says USFDA
New Jersey-based Sun Pharmaceutical Industries Inc, a unit of the company, has initiated the Class III nationwide (US) recall of the 10-count blister packs on October 12 this year.
Read More
Sun Pharma Q2 Net Profit Rises 13% To Rs 2,047 Cr
The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.
Read More
Sun Pharma, Cassiopea Spa Ink License & Supply Agreements For Acne Treatment Drug Winlevi
The USFDA approved Winlevi (clascoterone cream 1 per cent) in August 2020, for the topical treatment of acne vulgaris in patients 12 years and older.
Read More
Sun Pharma Settles Patent Litigation With Celgene Corporation For Cancer Drug Revlimid
Shares of Sun Pharma were trading 0.19 per cent lower at Rs 669.95 apiece on BSE.
Read More
Dilip Shanghvi Resigns As MD Of SPARC
Prior to joining SPARC, Raghavan served as the managing director of the India and Sri Lanka business of Quintiles, a global pharmaceutical services company.
Read More
Lupin, Sun Pharma, Jubilant Cadista Recall Drugs In US Market
The affected lot has been produced by Jubilant Generics at its Roorkee based plant in Uttarakhand and marketed in the US by Salisbury-based Jubilant Cadista Pharmaceuticals, Inc.
Read More
Markets Eke Out Slim Gains In Choppy Trade; RBI Policy Eyed
Domestic equities were quite volatile and gave up most initial gains as sharp spike in COVID-19 cases across the country and resultant mobility restrictions continued to weigh on investors’ sentiments
Read More